Related Experiment Video

Updated: Jun 8, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
05:31

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Published on: January 26, 2024

Diseases in children born to mothers with preeclampsia: a population-based sibling cohort study

Chun S Wu1, Ellen A Nohr, Bodil H Bech

  • 1Department of Epidemiology, School of Public Health, University of Aarhus, Aarhus, Denmark. cw@soci.au.dk

American Journal of Obstetrics and Gynecology
|September 30, 2010
PubMed

Insights

Preeclampsia exposure did not significantly alter offspring metabolic disease risk. However, prenatal exposure to preeclampsia was linked to increased respiratory disease risk in offspring, suggesting a potential programming effect.

Area of Science:

  • Perinatal Medicine
  • Pediatric Health
  • Epidemiology

Background:

  • Previous research indicated associations between preeclampsia and offspring metabolic and respiratory diseases.
  • The current study aimed to differentiate the effects of preeclampsia itself versus predisposing factors.

Purpose of the Study:

  • To investigate whether preeclampsia or its underlying causes are responsible for increased disease risks in offspring.
  • To analyze the specific risks for metabolic and respiratory diseases in children exposed to preeclampsia in utero.

Main Methods:

  • Utilized a Danish cohort of 22,264 discordant sibling pairs from 1978-2004.
  • Employed stratified Cox regression to compare exposed children with their unexposed siblings, calculating hazard ratios and confidence intervals for disease outcomes.

Main Results:

  • Offspring exposed to preeclampsia showed similar risks for metabolic disorders compared to unexposed siblings.
  • A statistically significant increased risk for respiratory diseases was observed in children exposed to preeclampsia (HR, 1.55; 95% CI, 1.20-2.01).

Conclusions:

  • While factors contributing to preeclampsia may influence offspring susceptibility to metabolic and respiratory conditions, a direct programming effect of preeclampsia on respiratory health cannot be excluded.
  • Further research is warranted to elucidate the mechanisms linking preeclampsia to long-term offspring health outcomes.
Abstract

More Related Videos

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis06:19

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis

Published on: January 7, 2018

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...